Evidence map›Paper›PMID 36135080›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy.

Hong Yu, Li Xu, Songcheng Yin, Jianlong Jiang, Chunhong Hong, Yulong He, Changhua Zhang

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hong YuDigestive Disease Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Li XuEmergency and Disaster Medicine Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Songcheng YinDigestive Disease Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Jianlong JiangDigestive Disease Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Chunhong HongDigestive Disease Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Yulong HeDigestive Disease Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Changhua ZhangDigestive Disease Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China.
Sun Yat-sen University · CNThe Seventh Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeoadjuvant chemotherapy is important to improve the prognosis of patients with advanced gastric cancer. However, it may result in postoperative complications (POCs). The aim of this study is to evaluate risk factors and prognostic impact of POCs in patients receiving neoadjuvant chemotherapy.

methodsWe retrospectively collected clinical information of patients who underwent curative gastrectomy after receiving neoadjuvant chemotherapy between 2011 and 2018. Overall survival (OS) was analyzed using the Kaplan-Meier method. Logistic regression and Fisher's exact test were used to evaluate risk factors for complications.

resultsA total of 176 patients were included in our study. The 3-year OS rates for the complication group (

conclusionsOur study revealed that patients with POCs had a poor prognosis and we identified the risk factors for complications so that POCs can be avoided in time.

Indexed as

Stomach NeoplasmsAlbuminsHumansNeoadjuvant TherapyPostoperative ComplicationsPrognosisRetrospective StudiesRisk FactorsAlbuminsgastric cancerneoadjuvant chemotherapypostoperative complication

Identifiers

PMID36135080
PMCPMC9498105
OpenAlexW4295592367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.